Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
Gralla J and Wiseman AC |
Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. |
2009 |
Transplantation |
pmid:19502965
|
Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Garcia-Criado FJ et al. |
Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. |
1997 |
Transplantation |
pmid:9293871
|
Suzuki H et al. |
Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. |
1997 |
Transplantation |
pmid:9293881
|
Asberg A et al. |
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. |
2006 |
Transplantation |
pmid:16861943
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Yang CW et al. |
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. |
2001 |
Transplantation |
pmid:11740384
|
Benito N et al. |
Alternariosis after liver transplantation. |
2001 |
Transplantation |
pmid:11740399
|
Moxey-Mims MM |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1999 |
Transplantation |
pmid:10440413
|
Schäffer MR et al. |
Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. |
1998 |
Transplantation |
pmid:9539093
|
McGhee B et al. |
Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. |
1997 |
Transplantation |
pmid:9326429
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Manez R et al. |
Rejection and hepatitis in liver transplants. |
1994 |
Transplantation |
pmid:7517080
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Chaftari AM et al. |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. |
2012 |
Transplantation |
pmid:22814329
|
Maruyama M et al. |
Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. |
1990 |
Transplantation |
pmid:1696410
|
Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Reichenspurner H et al. |
Optimization of the immunosuppressive protocol after lung transplantation. |
1999 |
Transplantation |
pmid:10428269
|
Pilmore HL et al. |
Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. |
2001 |
Transplantation |
pmid:11726837
|
Soccal PM et al. |
Improvement of drug-induced chronic renal failure in lung transplantation. |
1999 |
Transplantation |
pmid:10428288
|
Lee CM et al. |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. |
1997 |
Transplantation |
pmid:9371670
|
Ishizuka J et al. |
Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. |
1993 |
Transplantation |
pmid:7506454
|
Dhar DK et al. |
Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. |
1993 |
Transplantation |
pmid:7506456
|
Shao X et al. |
Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. |
2012 |
Transplantation |
pmid:23128973
|
Nicolai S and Bunyavanich S |
Hypersensitivity reaction to intravenous but not oral tacrolimus. |
2012 |
Transplantation |
pmid:23128975
|
Murase N et al. |
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. |
1990 |
Transplantation |
pmid:1700504
|
Burke MD et al. |
Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506. |
1990 |
Transplantation |
pmid:1700507
|
Størset E et al. |
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. |
2015 |
Transplantation |
pmid:25886918
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Shapiro R et al. |
Pediatric renal transplantation under tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10075598
|
Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Marcén R et al. |
Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. |
2006 |
Transplantation |
pmid:16570003
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Jain A et al. |
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. |
2000 |
Transplantation |
pmid:10653398
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Kihm LP et al. |
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. |
2012 |
Transplantation |
pmid:22470107
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Ciancio G et al. |
The use of Campath-1H as induction therapy in renal transplantation: preliminary results. |
2004 |
Transplantation |
pmid:15316372
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Hooper DK et al. |
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. |
2012 |
Transplantation |
pmid:22491658
|
Sarwal MM et al. |
Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. |
2003 |
Transplantation |
pmid:14627912
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. |
2008 |
Transplantation |
pmid:18622280
|
Bolin P et al. |
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results. |
2008 |
Transplantation |
pmid:18622283
|
Vignali D et al. |
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. |
2016 |
Transplantation |
pmid:27306531
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Berg UB et al. |
Renal function before and long after liver transplantation in children. |
2001 |
Transplantation |
pmid:11544422
|
Aw MM et al. |
Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. |
2001 |
Transplantation |
pmid:11544444
|
Gruessner RW et al. |
Mycophenolate mofetil in pancreas transplantation. |
1998 |
Transplantation |
pmid:9721799
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Terakura M et al. |
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. |
1998 |
Transplantation |
pmid:9721804
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Kershner RP and Fitzsimmons WE |
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. |
1996 |
Transplantation |
pmid:8878385
|
Richards KR et al. |
Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. |
2014 |
Transplantation |
pmid:24784360
|
Nolan TJ and Schad GA |
Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. |
1996 |
Transplantation |
pmid:8878405
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Klupp J et al. |
Indications of mycophenolate mofetil in liver transplantation. |
2005 |
Transplantation |
pmid:16286893
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Nankivell BJ et al. |
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. |
2016 |
Transplantation |
pmid:27306529
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Fukushima D et al. |
Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. |
2015 |
Transplantation |
pmid:24846306
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Marin-Casino M et al. |
Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. |
2014 |
Transplantation |
pmid:25243519
|
Reich DJ et al. |
Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. |
2005 |
Transplantation |
pmid:16003228
|
Hardinger KL et al. |
A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. |
2005 |
Transplantation |
pmid:16003231
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Bashuda H et al. |
Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. |
1996 |
Transplantation |
pmid:8693525
|
Egli A et al. |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. |
2013 |
Transplantation |
pmid:23274966
|
Nakajima K et al. |
Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506. |
1988 |
Transplantation |
pmid:2454521
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Pascual J et al. |
Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. |
2004 |
Transplantation |
pmid:15599321
|
Vathsala A et al. |
The immunosuppressive antagonism of low doses of FK506 and cyclosporine. |
1991 |
Transplantation |
pmid:1713361
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Kawano K et al. |
A protective effect of FK506 in ischemically injured rat livers. |
1991 |
Transplantation |
pmid:1713362
|
Hughes JR et al. |
Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. |
1999 |
Transplantation |
pmid:10480422
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Sun S et al. |
Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants. |
1996 |
Transplantation |
pmid:8633368
|
Kashu Y et al. |
The effect of combination splenectomy and low-dose FK506 therapy on graft survival after liver allograft transplantation in rats. |
1996 |
Transplantation |
pmid:8633382
|
Yilmaz MI et al. |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. |
2005 |
Transplantation |
pmid:16378057
|
Yoshimura N et al. |
A case report of pregnancy in renal transplant recipient treated with FK506 (tacrolimus). |
1996 |
Transplantation |
pmid:8633388
|
VÃtko S et al. |
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. |
2005 |
Transplantation |
pmid:16378069
|
Vacher-Coponat H et al. |
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. |
2012 |
Transplantation |
pmid:22228415
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|
Guitard J et al. |
Predictive factors for anemia six and twelve months after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16770241
|